LAURA BEACHAM: Open Payments
NPI 1124489380 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 36 payments from 9 companies in 2025. Trend: 2023 $1,097 · 2024 $566 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $281 |
| Organon LLC | 6 | $199 |
| Galderma Laboratories, L.P. | 3 | $173 |
| Arcutis Biotherapeutics, Inc. | 8 | $147 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
| Lilly USA, LLC | 2 | $53 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23 |
| Botanix SB Inc | 1 | $21 |
| LEO Pharma Inc. | 1 | $19 |
Products named: RINVOQ, NEMLUVIO, VTAMA, Zoryve, Rhapsido, TALTZ, Cabtreo, SOFDRA.
Industry payments across GA — which companies pay providers there.
